World Leading Microbiome Team

Our Mission

BiomeBank's mission is to treat and prevent disease by replenishing gut microbial ecology. The company has developed BiomeBoost which is used for the treatment of recurrent or refractory Clostridioides difficile infection. BiomeBank is developing a Pipeline of second generation microbial therapies in multiple indications.

Management Team

Thomas Mitchell

Chief Executive Officer

Sam Costello

Chief Medical Officer

Sam Forster

Chief Technology Officer

Aurelie Muhl

Head of Quality

Emily Tucker

Head of Donor Screening

Rob Bryant

VP Translational Medicine

Mirjana Rapaic

Head of Regulatory Affairs

Chelsea Bickley

Head of Production

Lisa Dann

Head of Microbiology

The BiomeBank Team

If you are interested in joining our dynamic team of scientists, we'd love to hear from you!